User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Novel pyrazolo[1,5-a]pyridines as PI3K inhibitors: variation of the central linker group

  • Open access
  • PDF
  • 458.15 K
  1. Shuttleworth Stephen, Silva Franck, Tomassi Cyrille, Cecil Alexander, Hill Thomas, Rogers Helen, Townsend Paul, Progress in the Design and Development of Phosphoinositide 3-Kinase (PI3K) Inhibitors for the Treatment of Chronic Diseases, Progress in Medicinal Chemistry (2009) ISBN:9780444533586 p.81-131, 10.1016/s0079-6468(09)04803-6
  2. Hollander M. Christine, Blumenthal Gideon M., Dennis Phillip A., PTEN loss in the continuum of common cancers, rare syndromes and mouse models, 10.1038/nrc3037
  3. Chaussade Claire, Cho Kitty, Mawson Claire, Rewcastle Gordon W., Shepherd Peter R., Functional differences between two classes of oncogenic mutation in the PIK3CA gene, 10.1016/j.bbrc.2009.02.081
  4. Cleary James M., Shapiro Geoffrey I., Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer, 10.1007/s11912-010-0091-6
  5. Liu Pixu, Cheng Hailing, Roberts Thomas M., Zhao Jean J., Targeting the phosphoinositide 3-kinase pathway in cancer, 10.1038/nrd2926
  6. Jamieson Stephen, Flanagan Jack U., Kolekar Sharada, Buchanan Christina, Kendall Jackie D., Lee Woo-Jeong, Rewcastle Gordon W., Denny William A., Singh Ripudaman, Dickson James, Baguley Bruce C., Shepherd Peter R., A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types, 10.1042/bj20110502
  7. Wu Peng, Hu Yongzhou, Small molecules targeting phosphoinositide 3-kinases, 10.1039/c2md20044a
  8. Markman Ben, J. Tao Jessica, Scaltriti Maurizio, PI3K Pathway Inhibitors: Better Not Left Alone, 10.2174/138161213804547213
  9. Kendall Jackie D., O’Connor Patrick D., Marshall Andrew J., Frédérick Raphaël, Marshall Elaine S., Lill Claire L., Lee Woo-Jeong, Kolekar Sharada, Chao Mindy, Malik Alisha, Yu Shuqiao, Chaussade Claire, Buchanan Christina, Rewcastle Gordon W., Baguley Bruce C., Flanagan Jack U., Jamieson Stephen M.F., Denny William A., Shepherd Peter R., Discovery of pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitors, 10.1016/j.bmc.2011.11.029
  10. Kendall Jackie D., Giddens Anna C., Tsang Kit Yee, Frédérick Raphaël, Marshall Elaine S., Singh Ripudaman, Lill Claire L., Lee Woo-Jeong, Kolekar Sharada, Chao Mindy, Malik Alisha, Yu Shuqiao, Chaussade Claire, Buchanan Christina, Rewcastle Gordon W., Baguley Bruce C., Flanagan Jack U., Jamieson Stephen M.F., Denny William A., Shepherd Peter R., Novel pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitors: Exploring the benzenesulfonohydrazide SAR, 10.1016/j.bmc.2011.11.031
  11. Nelson Sidney D., Metabolic activation and drug toxicity, 10.1021/jm00349a001
  12. Hayakawa Masahiko, Kaizawa Hiroyuki, Kawaguchi Ken-ichi, Ishikawa Noriko, Koizumi Tomonobu, Ohishi Takahide, Yamano Mayumi, Okada Minoru, Ohta Mitsuaki, Tsukamoto Shin-ichi, Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110α inhibitors, 10.1016/j.bmc.2006.09.047
  13. Berndt Alex, Miller Simon, Williams Olusegun, Le Daniel D, Houseman Benjamin T, Pacold Joseph I, Gorrec Fabrice, Hon Wai-Ching, Liu Yi, Rommel Christian, Gaillard Pascale, Rückle Thomas, Schwarz Matthias K, Shokat Kevan M, Shaw Jeffrey P, Williams Roger L, The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors, 10.1038/nchembio.293
  14. Lipinski Christopher A., Lombardo Franco, Dominy Beryl W., Feeney Paul J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, 10.1016/s0169-409x(96)00423-1
  15. Kaboudin Babak, Elhamifar Dawood, Phosphorus Pentasulfide: A Mild and Versatile Reagent for the Preparation of Thioamides from Nitriles, 10.1055/s-2005-918507
  16. Yokoyama Masataka, Hatanaka Hidekatsu, Preparative Methods for Dialkyl Dithioseleno- and Thiodiselenocarbonates, 10.1055/s-1985-31374
  17. Rasmussen C. R., Villani, Jr. F. J., Weaner L. E., Reynolds B. E., Hood A. R., Hecker L. R., Nortey S. O., Hanslin A., Costanzo M. J., Powell E. T., Molinari A. J., Improved Procedures for the Preparation of Cycloalkyl-, Arylalkyl-, and Arylthioureas, 10.1055/s-1988-27605
  18. Mahboobi Siavosh, Dove Stefan, Sellmer Andreas, Winkler Matthias, Eichhorn Emerich, Pongratz Herwig, Ciossek Thomas, Baer Thomas, Maier Thomas, Beckers Thomas, Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases†, 10.1021/jm800988r
  19. Prokopcová Hana, Kappe C. Oliver, Palladium(0)-Catalyzed, Copper(I)-Mediated Coupling of Boronic Acids with Cyclic Thioamides. Selective Carbon−Carbon Bond Formation for the Functionalization of Heterocycles†, 10.1021/jo070408f
  20. Chaussade Claire, Rewcastle Gordon W., Kendall Jackie D., Denny William A., Cho Kitty, Grønning Line M., Chong Mei Ling, Anagnostou Sasha H., Jackson Shaun P., Daniele Nathalie, Shepherd Peter R., Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling, 10.1042/bj20070003
Bibliographic reference Kendall, Jackie D. ; Marshall, Andrew J. ; Giddens, Anna C. ; Tsang, Kit Yee ; Boyd, Maruta ; et. al. Novel pyrazolo[1,5-a]pyridines as PI3K inhibitors: variation of the central linker group. In: MedChemComm, Vol. 5, no.1, p. 41 [1-6] (2014)
Permanent URL http://hdl.handle.net/2078.1/145674